Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

LabCorp licenses diagnostic technology for Alzheimer's disease

April 5, 2012

Ajinomoto in-licenses IBAT inhibitor

April 4, 2012

Amgen and AstraZeneca to jointly develop inflammation portfolio candidates

April 4, 2012

Forest Laboratories acquires intellectual property from Janssen

April 4, 2012

PolyTherics and Spirogen to collaborate on novel ADCs for cancer

April 3, 2012

Synageva BioPharma and Mitsubishi Tanabe Pharma expand collaboration

April 3, 2012

Novartis Nanobody candidate clear to enter phase I trial

April 3, 2012

Minophagen granted additional rights to bexarotene

April 2, 2012

Myriad Genetics and Cephalon enter agreement for mutation testing in phase I/II study

April 2, 2012

Allergan obtains rights for Ameluz in Spain

April 2, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...